Clinuvel Pharmaceuticals Limited (ASX:CUV)
Australia · Delayed Price · Currency is AUD 11.56
-0.43 (-3.59%)
Oct 17, 2025, 4:10 PM AEST
Clinuvel Pharmaceuticals Market Cap
Clinuvel Pharmaceuticals has a market cap or net worth of 580.32 million as of October 17, 2025. Its market cap has decreased by -18.19% in one year.
Market Cap
580.32M
Enterprise Value
356.74M
Revenue
95.02M
Ranking
n/a
PE Ratio
16.10
Stock Price
11.56
Market Cap Chart
Since February 13, 2001, Clinuvel Pharmaceuticals's market cap has increased from 5.23M to 580.32M, an increase of 11,005.20%. That is a compound annual growth rate of 21.02%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Oct 17, 2025 | 580.32M | -3.88% |
| Dec 31, 2024 | 603.73M | -24.73% |
| Dec 29, 2023 | 802.04M | -25.09% |
| Dec 30, 2022 | 1.07B | -20.36% |
| Dec 31, 2021 | 1.34B | 21.91% |
| Dec 31, 2020 | 1.10B | -21.55% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2015 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| CSL Limited | 105.61B |
| Pro Medicus | 29.85B |
| Cochlear | 18.68B |
| Sonic Healthcare | 10.71B |
| Ramsay Health Care | 7.27B |
| Telix Pharmaceuticals | 5.63B |
| Ansell | 4.82B |
| Mesoblast | 3.35B |